Loading...
•
Dec 31, 2021
Waters Q4 2021 Earnings Report
Waters' Q4 2021 financial results were reported, with sales increasing by 6% and EPS increasing to $3.52.
Key Takeaways
Waters Corporation reported a 6% increase in sales to $836 million for Q4 2021 compared to $787 million in Q4 2020. GAAP EPS increased to $3.52 from $3.49, and non-GAAP EPS increased to $3.67 from $3.65. The company saw strong momentum in revenue growth, particularly in biopharma, industrial, and China.
Fourth quarter sales reached $836 million, reflecting a 6% increase as reported and an 8% increase in constant currency.
Instrument sales led the quarter with double-digit growth, showing increased momentum into year-end.
GAAP EPS for the fourth quarter increased to $3.52, while non-GAAP EPS rose to $3.67.
The company experienced broad-based growth across end markets and geographies, with notable strength in biopharma, industrial, and China.
Waters
Waters
Waters Revenue by Segment
Waters Revenue by Geographic Location
Revenue by Segment
Waters Instrument Systems Revenue
CapyFin.comTA Instrument Systems Revenue
CapyFin.comRevenue by Geographic Location
Asia Revenue
CapyFin.comAmericas Revenue
CapyFin.comEurope Revenue
CapyFin.com Forward Guidance
The Company expects full-year 2022 constant currency sales growth in the range of 5% to 7%. The Company expects full-year 2022 non-GAAP EPS in the range of $11.75 to $12.00.
Positive Outlook
- Full-year 2022 constant currency sales growth in the range of 5% to 7%.
- Full-year 2022 non-GAAP EPS in the range of $11.75 to $12.00.
- First quarter 2022 constant currency sales growth in the range of 6% to 8%.
- First quarter 2022 non-GAAP EPS in the range of $2.25 to $2.35.
Challenges Ahead
- Currency translation is expected to decrease full-year sales growth by approximately one percentage point.
- Currency translation is expected to decrease first quarter sales growth by approximately three percentage points.
Revenue & Expenses
Visualization of income flow from segment revenue to net income